To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Treatment-related deaths … - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Treatment-related deaths in second complete remission in childhood acute myeloid leukaemia.

Journal article
Authors Lene Molgaard-Hansen
Merja Möttönen
Heidi Glosli
Guðmundur K Jónmundsson
Jonas Abrahamsson
Henrik Hasle
Lotta Mellander
Published in British journal of haematology
Volume 152
Issue 5
Pages 623-30
ISSN 1365-2141
Publication year 2011
Published at Institute of Clinical Sciences, Department of Pediatrics
Pages 623-30
Language en
Keywords Adolescent, Antineoplastic Combined Chemotherapy Protocols, adverse effects, therapeutic use, Child, Child, Preschool, Disease Progression, Epidemiologic Methods, Female, Graft vs Host Disease, mortality, Hematopoietic Stem Cell Transplantation, adverse effects, Humans, Infant, Leukemia, Myeloid, Acute, drug therapy, mortality, Male, Opportunistic Infections, mortality, Recurrence, Remission Induction, Scandinavia, epidemiology
Subject categories Cancer and Oncology, Children


The frequency and causes of treatment-related deaths (TRD) in second complete remission (CR2) in acute myeloid leukaemia (AML) were investigated in a historical, prospective cohort study of 429 children included in the Nordic Society of Paediatric Haematology and Oncology (NOPHO)-AML-88 and -93 trials. Relapse occurred in 158 children (39%). Seventeen (18%) of the 96 patients entering CR2 suffered TRD. The main causes were infection (59%) and complications from graft-versus-host disease (22%). Fourteen (82%) of 17 TRDs occurred in children undergoing haematopoietic stem cell transplantations (HSCT). Optimal supportive care after HSCT is essential, and studies on risk factors for TRD are needed.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?